Completed PHASE2 INTERVENTIONAL 2-arm NCT05051501

The Effects of Microbiological Spectrum Changes to Improve Cognitive Health in Aging Population (CleverAgeBiota)

Biotechnology Research Into Microbiological Spectrum Changes to Improve Cognitive Functions, Depression and Other Neuropsychiatric Disorders in Aging Population

Sponsor: C2P s.r.o.

Conditions Aging Aging Problems Cognitive Decline Gut Health Memory Deficits Mood Change

Interventions Probiotics C2P

Updated 5 times since 2021 Last updated: May 31, 2023 Started: Jan 6, 2021 Primary completion: Mar 2, 2022 Completion: Mar 2, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05051501, this PHASE2 trial focuses on Aging and Aging Problems and remains completed. Sponsored by C2P s.r.o., it has been updated 5 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jul 2023 — Jul 2024 [monthly]

Completed PHASE2

Status: Active Not Recruiting → Completed
Dec 2021 — Jul 2023 [monthly]

Active Not Recruiting PHASE2

Status: Recruiting → Active Not Recruiting
Oct 2021 — Dec 2021 [monthly]

Recruiting PHASE2

First recorded

Jan 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

C2P s.r.o.
Ministry of Industry and Trade, Czech Republic
National Institute of Mental Health, Czech Republic
University Hospital Vinohrady

Data source: National Institute of Mental Health, Czech Republic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Prague, Czechia